Interview Intersection: Expert Interviews From August 2024

Naiem Issa, MD, PhD, shared highlights from his sessions on the 1726 nm laser for acne, atopic dermatitis disease modification, advances in hidradenitis suppurativa, and microneedling techniques for vitiligo.

Q&A: Biologic Therapies in Pediatric Dermatology - Vaccines, Adverse Effects, and Personalized Care

Michele Ramien, MD, discusses biologic therapies for pediatric dermatology, focusing on their impact on vaccines, managing side effects, and tailoring treatment.

Diving Into Deuruxolitinib Data With Natasha Mesinkovska, MD, PhD

The investigator in the clinical development program for deuruxolitinib shared data, patient populations to consider, and more in a recent interview.

Q&A: DaRT Guidelines for Nonmelanoma Skin Cancer Care

Jacob Scott, MD, president and chairman of DaRT, shares highlights of the guidelines and what he hopes clinicians can glean from them.

Q&A: Alumis Inc. Initiates Phase 3 Clinical Program for ESK-001 in Plaque Psoriasis

Alumis' Martin Babler shared insights into the program for the TYK2 inhibitor and the company's next steps for its development.

Topics and Pearls

Disease states such as psoriasis, hidradenitis suppurativa, eczema, CTCL, and alopecia
Insights into nonmelanoma skin cancer advances
Pearls for pediatric dermatology, aesthetic concerns, and skin of color
Conference data and pearls

Insights Into Positive Decision for Galderma's RelabotulinumtoxinA in Europe

Sachin Shridharani, MD, FACS, discusses the READY-1 and READY-2 clinical trials and positive support for Relfydess.

Q&A: Study Highlights KT-474's Effectiveness in Targeting IRAK4 for Hidradenitis Suppurativa and Other Inflammatory Diseases

Jared Gollob, MD, shares highlights of Kymera Therapeutics' recent JID publication.

Chesahna Kindred, MD, MBA, FAAD: Expert Insights on Enhancing Dermatological Care for Patients with Skin of Color

Kindred spoke with Dermatology Times to discuss AbbVie's recent Science of Skin event and improving access to equitable dermatological care.

“My Skin My Story” Provides Creative Outlet for Young Patients With Eczema

John Browning, MD, FAAD, FAAP, MBA, discusses the new online platform that allows young patients to share their skin journey with others.

Insights Into the Approval of Denileukin Diftitox-cxdl for Cutaneous T-Cell Lymphoma

Myron Czuczman, MD, of Citius Pharmaceuticals recently shared perspectives on the role and potential of Lymphir in CTCL.

Tailoring Aesthetic Treatments for Patients With Skin of Color

Omer Ibrahim, MD, discusses the nuances of aesthetic procedures for patients with skin of color and the importance of tailored treatments, safety, and improved clinician education.

Q&A: Pelage's Novel PP405 Advances to Phase 2a for Androgenetic Alopecia

Qing Yu Christina Weng, MD, shares insights into the drug's advancement following preliminary phase 1 findings.

Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.